Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

737
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
737
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

429
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
429
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

488
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
488
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

881
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
881
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.3K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.3K
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

276
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
276

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association Between Severe Anaemia and Outcome in Moderate and Severe Traumatic Brain Injury: A Retrospective Cohort Study.

Acta anaesthesiologica Scandinavica·2026
Same author

New Diagnostic Criteria for Mild Traumatic Brain Injury: Medical-Legal Considerations.

Archives of physical medicine and rehabilitation·2025
Same author

Examining and comparing the clinical characteristics of adults with persisting post-concussion symptoms presenting for outpatient rehabilitation following a mild traumatic brain injury or a minimal head injury.

Journal of rehabilitation medicine·2025
Same author

Postmortem tau in the CA2 region of the hippocampus in older adult men who participated in youth amateur American-style football.

Journal of Alzheimer's disease : JAD·2025
Same author

Cognitive weaknesses or impairments on the NIH toolbox cognition battery in children and adolescents: base rates in a normative sample and proposed methods for classification.

Frontiers in psychology·2025
Same author

Long-Term Mortality of Patients With Head Injuries-A 10-Year Follow-up Study With Population Controls Study Performed at Tampere University Hospital.

Neurosurgery·2025

Related Experiment Video

Updated: Oct 13, 2025

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
09:14

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

Published on: June 18, 2021

2.5K

Serotonergic Antidepressants and Risk for Traumatic Intracranial Bleeding.

Harri Isokuortti1, Grant L Iverson2, Jussi P Posti3

  • 1Department of Neurosurgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Frontiers in Neurology
|November 15, 2021
PubMed
Summary

Serotonergic antidepressant use did not increase the risk of traumatic intracranial bleeding in head injury patients. This study found no significant association between antidepressant medication and intracranial hemorrhage in trauma cases.

Keywords:
anticoagulationantidepressant agentsantithrombotic agents (MeSH)brain injuriesintracranial hemorrhagestraumatic

More Related Videos

Controlled Cortical Impact Model for Traumatic Brain Injury
05:30

Controlled Cortical Impact Model for Traumatic Brain Injury

Published on: August 5, 2014

29.0K
Murine Model of Controlled Cortical Impact for the Induction of Traumatic Brain Injury
05:01

Murine Model of Controlled Cortical Impact for the Induction of Traumatic Brain Injury

Published on: August 16, 2019

10.7K

Related Experiment Videos

Last Updated: Oct 13, 2025

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
09:14

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

Published on: June 18, 2021

2.5K
Controlled Cortical Impact Model for Traumatic Brain Injury
05:30

Controlled Cortical Impact Model for Traumatic Brain Injury

Published on: August 5, 2014

29.0K
Murine Model of Controlled Cortical Impact for the Induction of Traumatic Brain Injury
05:01

Murine Model of Controlled Cortical Impact for the Induction of Traumatic Brain Injury

Published on: August 16, 2019

10.7K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Trauma Surgery

Background:

  • Serotonergic antidepressants are known to increase bleeding risk.
  • The impact of these medications on traumatic intracranial bleeding remains unclear.

Purpose of the Study:

  • To investigate the association between serotonergic antidepressant use and traumatic intracranial hemorrhage.
  • To determine if antidepressant medication affects bleeding risk in head trauma patients.

Main Methods:

  • A cohort study of 2,890 adult head trauma patients from a Finnish tertiary center emergency department (2010-2012).
  • Compared rates of intracranial bleeding in patients using antidepressants versus those not using them.
  • Utilized head CT scans to identify intracranial bleeding and performed regression analysis.

Main Results:

  • Male gender, low Glasgow Coma Scale (GCS) score (<15), older age, and anticoagulation were linked to higher bleeding risk.
  • No statistically significant difference in traumatic intracranial bleeding rates was observed between antidepressant users (18.3%) and non-users (17.8%).
  • Antidepressant use did not show an association with traumatic intracranial hemorrhage in regression analysis.

Conclusions:

  • Serotonergic antidepressant use is not associated with an increased risk of traumatic intracranial hemorrhage.
  • Findings suggest current antidepressant medications do not elevate the risk of bleeding in the context of acute head injury.